✦ LIBER ✦

HSPA5 promoter polymorphisms and risk of Parkinson's disease in Taiwan

✍ Scribed by Chiung-Mei Chen; Yih-Ru Wu; Fen-Ju Hu; Yi-Chun Chen; Tzu-Jung Chuang; Ya-Fen Cheng; Guey-Jen Lee-Chen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitochondrial DNA polymorphisms and the

✍ C. M. Chen; C. C. Kuan; G.-J. Lee-Chen; Y. R. Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 69 KB

LINGO-2 polymorphism and the risk of Par

✍ Feng-Chieh Su; Chiung-Mei Chen; Yi-Chun Chen; Yih-Ru Wu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Interleukin-18 promoter polymorphisms an

✍ Xiang Xu; Dequan Li; Qing He; Jing Gao; Biao Chen; Anmu Xie 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 187 KB

ATXN8 −62 G/A promoter polymorphism and

✍ I.-C. Chen; Y.-R. Wu; S.-J. Yang; S.-H. Kao; Y.-C. Chen; K.-H. Chang; C.-M. Lee; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

DMT1 polymorphism and risk of Parkinson’

✍ Qing He; Tingting Du; Xiaojun Yu; Anmu Xie; Ning Song; Qi Kang; Jintai Yu; Lan T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Mitochondrial DNA polymorphisms and risk

✍ Cecilia Huerta; Mónica G. Castro; Eliecer Coto; Marta Blázquez; René Ribacoba; L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB